Takeda Pharmaceutical Co LtdNYSE:TAK
No Matches were found for
- LAST PRICE13.2200
- TODAY'S CHANGE (%)-0.0900 (-0.6762%)
- Bid / Lots13.0000/ 11
- Ask / Lots13.4700/ 1
- Open / Previous Close13.2800 / 13.3100
- Day Range
- 52 Week Range
- Volume1,009,727
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
Select an index
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | TAK |
|---|---|---|
| 09:32 ET | 21311 | 13.28 |
| 09:34 ET | 3209 | 13.255 |
| 09:36 ET | 8301 | 13.2475 |
| 09:38 ET | 5799 | 13.23 |
| 09:39 ET | 6017 | 13.225 |
| 09:41 ET | 5165 | 13.24 |
| 09:43 ET | 1250 | 13.24 |
| 09:45 ET | 120 | 13.245 |
| 09:48 ET | 353 | 13.245 |
| 09:50 ET | 600 | 13.25 |
| 09:52 ET | 400 | 13.25 |
| 09:54 ET | 1421 | 13.25 |
| 09:56 ET | 1867 | 13.245 |
| 09:57 ET | 725 | 13.245 |
| 09:59 ET | 100 | 13.245 |
| 10:01 ET | 5785 | 13.24 |
| 10:03 ET | 2180 | 13.25 |
| 10:06 ET | 100 | 13.25 |
| 10:08 ET | 400 | 13.25 |
| 10:10 ET | 1853 | 13.25 |
| 10:12 ET | 5074 | 13.25 |
| 10:14 ET | 751 | 13.25 |
| 10:15 ET | 400 | 13.245 |
| 10:17 ET | 2926 | 13.24 |
| 10:19 ET | 800 | 13.24 |
| 10:21 ET | 2186 | 13.24 |
| 10:24 ET | 3804 | 13.235 |
| 10:26 ET | 742 | 13.23 |
| 10:28 ET | 1100 | 13.235 |
| 10:30 ET | 640 | 13.235 |
| 10:32 ET | 1073 | 13.235 |
| 10:33 ET | 2044 | 13.23 |
| 10:35 ET | 1976 | 13.23 |
| 10:37 ET | 18637 | 13.235 |
| 10:39 ET | 4990 | 13.235 |
| 10:42 ET | 400 | 13.24 |
| 10:44 ET | 214 | 13.24 |
| 10:46 ET | 200 | 13.235 |
| 10:48 ET | 1500 | 13.235 |
| 10:50 ET | 12977 | 13.265 |
| 10:51 ET | 900 | 13.265 |
| 10:53 ET | 2617 | 13.27 |
| 10:55 ET | 1300 | 13.27 |
| 10:57 ET | 6352 | 13.27 |
| 11:00 ET | 300 | 13.28 |
| 11:02 ET | 15662 | 13.27 |
| 11:04 ET | 100 | 13.265 |
| 11:06 ET | 1700 | 13.265 |
| 11:08 ET | 900 | 13.2654 |
| 11:09 ET | 585 | 13.265 |
| 11:11 ET | 1100 | 13.265 |
| 11:13 ET | 887 | 13.267 |
| 11:15 ET | 1031 | 13.2601 |
| 11:18 ET | 378 | 13.265 |
| 11:20 ET | 1113 | 13.27 |
| 11:22 ET | 500 | 13.265 |
| 11:24 ET | 1924 | 13.27 |
| 11:26 ET | 500 | 13.265 |
| 11:27 ET | 8364 | 13.26 |
| 11:29 ET | 1700 | 13.25 |
| 11:31 ET | 200 | 13.26 |
| 11:33 ET | 5116 | 13.25 |
| 11:36 ET | 1123 | 13.245 |
| 11:40 ET | 1100 | 13.245 |
| 11:42 ET | 100 | 13.245 |
| 11:44 ET | 1000 | 13.245 |
| 11:45 ET | 400 | 13.245 |
| 11:47 ET | 1058 | 13.245 |
| 11:49 ET | 317 | 13.25 |
| 11:51 ET | 1772 | 13.2499 |
| 11:54 ET | 1921 | 13.245 |
| 11:56 ET | 4412 | 13.245 |
| 11:58 ET | 300 | 13.25 |
| 12:00 ET | 312 | 13.245 |
| 12:02 ET | 20004 | 13.24 |
| 12:03 ET | 595 | 13.241 |
| 12:05 ET | 5002 | 13.2436 |
| 12:07 ET | 2139 | 13.245 |
| 12:09 ET | 200 | 13.245 |
| 12:12 ET | 300 | 13.245 |
| 12:14 ET | 200 | 13.245 |
| 12:16 ET | 1500 | 13.245 |
| 12:18 ET | 1300 | 13.24 |
| 12:20 ET | 37341 | 13.265 |
| 12:21 ET | 1209 | 13.265 |
| 12:23 ET | 3364 | 13.265 |
| 12:25 ET | 4973 | 13.27 |
| 12:27 ET | 1200 | 13.27 |
| 12:30 ET | 400 | 13.265 |
| 12:32 ET | 1957 | 13.265 |
| 12:34 ET | 3239 | 13.27 |
| 12:36 ET | 1000 | 13.265 |
| 12:38 ET | 1871 | 13.27 |
| 12:39 ET | 882 | 13.27 |
| 12:41 ET | 3460 | 13.265 |
| 12:43 ET | 5446 | 13.265 |
| 12:45 ET | 9561 | 13.27 |
| 12:48 ET | 5469 | 13.28 |
| 12:50 ET | 1746 | 13.275 |
| 12:52 ET | 10153 | 13.275 |
| 12:54 ET | 620 | 13.275 |
| 12:56 ET | 20265 | 13.26 |
| 12:57 ET | 125 | 13.2612 |
| 12:59 ET | 400 | 13.265 |
| 01:01 ET | 6467 | 13.265 |
| 01:03 ET | 547 | 13.2617 |
| 01:06 ET | 400 | 13.265 |
| 01:08 ET | 9309 | 13.255 |
| 01:10 ET | 8867 | 13.265 |
| 01:12 ET | 20114 | 13.255 |
| 01:14 ET | 687 | 13.2581 |
| 01:15 ET | 100 | 13.255 |
| 01:17 ET | 600 | 13.255 |
| 01:19 ET | 1298 | 13.255 |
| 01:21 ET | 5836 | 13.255 |
| 01:24 ET | 200 | 13.25 |
| 01:26 ET | 900 | 13.2502 |
| 01:28 ET | 729 | 13.2501 |
| 01:30 ET | 500 | 13.25 |
| 01:32 ET | 517 | 13.255 |
| 01:33 ET | 600 | 13.26 |
| 01:35 ET | 13465 | 13.24 |
| 01:37 ET | 30314 | 13.245 |
| 01:39 ET | 884 | 13.245 |
| 01:42 ET | 100 | 13.245 |
| 01:44 ET | 2200 | 13.24 |
| 01:46 ET | 500 | 13.245 |
| 01:48 ET | 300 | 13.24 |
| 01:50 ET | 5800 | 13.245 |
| 01:51 ET | 31286 | 13.225 |
| 01:53 ET | 5509 | 13.2399 |
| 01:55 ET | 512 | 13.235 |
| 01:57 ET | 400 | 13.235 |
| 02:00 ET | 1278 | 13.24 |
| 02:02 ET | 1658 | 13.235 |
| 02:04 ET | 853 | 13.235 |
| 02:06 ET | 795 | 13.23 |
| 02:08 ET | 279 | 13.24 |
| 02:09 ET | 1568 | 13.235 |
| 02:11 ET | 631 | 13.235 |
| 02:13 ET | 13212 | 13.2305 |
| 02:15 ET | 22036 | 13.225 |
| 02:18 ET | 2394 | 13.225 |
| 02:20 ET | 1408 | 13.225 |
| 02:22 ET | 900 | 13.225 |
| 02:24 ET | 1432 | 13.225 |
| 02:26 ET | 2495 | 13.23 |
| 02:27 ET | 1005 | 13.23 |
| 02:29 ET | 5213 | 13.23 |
| 02:31 ET | 1900 | 13.23 |
| 02:33 ET | 1223 | 13.225 |
| 02:36 ET | 1500 | 13.225 |
| 02:38 ET | 2776 | 13.225 |
| 02:40 ET | 1248 | 13.225 |
| 02:42 ET | 18294 | 13.24 |
| 02:44 ET | 24349 | 13.23 |
| 02:45 ET | 798 | 13.225 |
| 02:47 ET | 1900 | 13.225 |
| 02:49 ET | 800 | 13.22 |
| 02:51 ET | 1600 | 13.225 |
| 02:54 ET | 1270 | 13.22 |
| 02:56 ET | 1817 | 13.225 |
| 02:58 ET | 2144 | 13.225 |
| 03:00 ET | 1761 | 13.23 |
| 03:02 ET | 45264 | 13.215 |
| 03:03 ET | 1393 | 13.2199 |
| 03:05 ET | 380 | 13.21 |
| 03:07 ET | 2291 | 13.215 |
| 03:09 ET | 2780 | 13.22 |
| 03:12 ET | 1538 | 13.215 |
| 03:14 ET | 775 | 13.22 |
| 03:16 ET | 19709 | 13.215 |
| 03:18 ET | 5492 | 13.215 |
| 03:20 ET | 1500 | 13.22 |
| 03:21 ET | 2131 | 13.21 |
| 03:23 ET | 1700 | 13.22 |
| 03:25 ET | 2208 | 13.215 |
| 03:27 ET | 800 | 13.22 |
| 03:30 ET | 16324 | 13.225 |
| 03:32 ET | 2426 | 13.22 |
| 03:34 ET | 2781 | 13.225 |
| 03:36 ET | 3209 | 13.225 |
| 03:38 ET | 16522 | 13.22 |
| 03:39 ET | 900 | 13.215 |
| 03:41 ET | 1612 | 13.215 |
| 03:43 ET | 3366 | 13.215 |
| 03:45 ET | 6432 | 13.215 |
| 03:48 ET | 2863 | 13.215 |
| 03:50 ET | 8617 | 13.22 |
| 03:52 ET | 16920 | 13.215 |
| 03:54 ET | 58453 | 13.22 |
| 03:56 ET | 12041 | 13.23 |
| 03:57 ET | 10207 | 13.225 |
| 03:59 ET | 18351 | 13.22 |
Yesterday
Takeda Canada Inc. concludes Letter of Intent (LOI) with the pan-Canadian Pharmaceutical Alliance (pCPA) for LIVTENCITY (maribavir) for the treatment of adults with a post-transplant cytomegalovirus (CMV) infection, from 8:02AM ET on Thursday May 16, 2024 by Dow Jones
8:02AM ET on Thursday May 16, 2024 by Dow Jones
May 14, 2024
Takeda to Present Oncology Portfolio and Pipeline Data at the 2024 ASCO Annual Meeting, from 8:00AM ET on Tuesday May 14, 2024 by Dow Jones
8:00AM ET on Tuesday May 14, 2024 by Dow Jones
May 13, 2024
DJ AC Immunity Shares Soar on Exclusive License Deal with Takeda, from 7:11AM ET on Monday May 13, 2024 by Dow Jones
7:11AM ET on Monday May 13, 2024 by Dow JonesAC Immune and Takeda Sign Exclusive Option and License Agreement for Active Immunotherapy Targeting Amyloid Beta for Alzheimer's Disease, from 6:00AM ET on Monday May 13, 2024 by Dow Jones
6:00AM ET on Monday May 13, 2024 by Dow Jones
May 9, 2024
DJ Takeda Pharmaceutical Projects Lower Annual Profit After Quarterly Loss -- Update, from 3:22AM ET on Thursday May 09, 2024 by Dow Jones
3:22AM ET on Thursday May 09, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Takeda Pharmaceutical Co Ltd | 42.3B | 45.0x | -8.01% |
Xeris Biopharma Holdings Inc | 299.5M | -4.3x | --- |
Assertio Holdings Inc | 97.0M | -0.3x | --- |
Natural Alternatives International Inc | 41.9M | -9.3x | -18.19% |
SCYNEXIS Inc | 91.0M | 1.4x | --- |
LifeVantage Corp | 91.5M | 24.3x | -16.83% |
Company Information
Takeda Pharmaceutical Company Limited is a Japan-based company mainly engaged in the pharmaceutical business. The Company is engaged in the research, development, manufacture and sale of pharmaceutical products, General medical products, quasi drugs and healthcare products in Japan and overseas. The Company's research and development functions are concentrated in four areas of oncology (cancer), digestive system diseases, rare diseases and neurology (neuropsychiatric diseases), as well as two business units of plasma fractionation products and vaccines. The Company is engaged in the improvement of pipelines at research and development centers located mainly in Japan and the United States.
Contact Information
- Headquarters
- 4F, 2-1-1, Nihombashihon-choCHUO-KU, TKY, Japan 103-8668
- Phone
- ---
- Fax
- ---
Executives
- Chairman of Board of Directors, Independent Director
- Masami Iijima
- President, Chief Executive Officer, Representative Director
- Christophe Weber
- Chief Financial Officer, Director
- Costa Saroukos
- President of Research & Development, Vice President of Subsidiary, Director
- Andrew Plump
- Independent Director
- Jean-Luc Butel
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $42.3B |
|---|---|
Revenue (TTM) | $27.4B |
Shares Outstanding | 3.2B |
Dividend Yield | 7.25% |
Annual Dividend Rate | 0.9586 USD |
Ex-Dividend Date | 09-27-23 |
Pay Date | 12-11-23 |
Beta | 0.59 |
EPS | $0.29 |
Book Value | $14.92 |
P/E Ratio | 45.0x |
Price/Sales (TTM) | 1.5 |
Price/Cash Flow (TTM) | 7.5x |
Operating Margin | 5.02% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
